Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for TEAD3_TEAD1
Z-value: 2.76
Motif logo
Transcription factors associated with TEAD3_TEAD1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TEAD3
|
ENSG00000007866.14 | TEA domain transcription factor 3 |
|
TEAD1
|
ENSG00000187079.10 | TEA domain transcription factor 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TEAD3 | hg19_v2_chr6_-_35464817_35464894 | 0.77 | 7.2e-05 | Click! |
| TEAD1 | hg19_v2_chr11_+_12696102_12696164 | 0.32 | 1.8e-01 | Click! |
Activity profile of TEAD3_TEAD1 motif
Sorted Z-values of TEAD3_TEAD1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr1_+_183155373 | 17.38 |
ENST00000493293.1
ENST00000264144.4 |
LAMC2
|
laminin, gamma 2 |
| chr17_-_39677971 | 15.83 |
ENST00000393976.2
|
KRT15
|
keratin 15 |
| chr19_-_51472031 | 14.73 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51472222 | 14.04 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
| chr15_+_39873268 | 13.79 |
ENST00000397591.2
ENST00000260356.5 |
THBS1
|
thrombospondin 1 |
| chr1_-_59043166 | 13.69 |
ENST00000371225.2
|
TACSTD2
|
tumor-associated calcium signal transducer 2 |
| chr6_+_30850697 | 12.29 |
ENST00000509639.1
ENST00000412274.2 ENST00000507901.1 ENST00000507046.1 ENST00000437124.2 ENST00000454612.2 ENST00000396342.2 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr14_-_23446900 | 10.56 |
ENST00000556731.1
|
AJUBA
|
ajuba LIM protein |
| chr6_-_42110342 | 10.27 |
ENST00000356542.5
|
C6orf132
|
chromosome 6 open reading frame 132 |
| chr2_+_208104351 | 9.68 |
ENST00000440326.1
|
AC007879.7
|
AC007879.7 |
| chr3_+_171844762 | 9.65 |
ENST00000443501.1
|
FNDC3B
|
fibronectin type III domain containing 3B |
| chr17_-_39093672 | 9.53 |
ENST00000209718.3
ENST00000436344.3 ENST00000485751.1 |
KRT23
|
keratin 23 (histone deacetylase inducible) |
| chr3_-_112360116 | 9.22 |
ENST00000206423.3
ENST00000439685.2 |
CCDC80
|
coiled-coil domain containing 80 |
| chr19_+_35606692 | 8.06 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr2_+_208104497 | 7.76 |
ENST00000430494.1
|
AC007879.7
|
AC007879.7 |
| chr6_-_128841503 | 7.56 |
ENST00000368215.3
ENST00000532331.1 ENST00000368213.5 ENST00000368207.3 ENST00000525459.1 ENST00000368210.3 ENST00000368226.4 ENST00000368227.3 |
PTPRK
|
protein tyrosine phosphatase, receptor type, K |
| chr12_-_28122980 | 7.31 |
ENST00000395868.3
ENST00000534890.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr4_-_187644930 | 7.18 |
ENST00000441802.2
|
FAT1
|
FAT atypical cadherin 1 |
| chr11_+_66824303 | 6.96 |
ENST00000533360.1
|
RHOD
|
ras homolog family member D |
| chr10_+_24498060 | 6.73 |
ENST00000376454.3
ENST00000376452.3 |
KIAA1217
|
KIAA1217 |
| chr1_+_78354175 | 6.72 |
ENST00000401035.3
ENST00000457030.1 ENST00000330010.8 |
NEXN
|
nexilin (F actin binding protein) |
| chr11_+_66824276 | 6.67 |
ENST00000308831.2
|
RHOD
|
ras homolog family member D |
| chr17_+_4901199 | 6.67 |
ENST00000320785.5
ENST00000574165.1 |
KIF1C
|
kinesin family member 1C |
| chr19_-_51512804 | 6.66 |
ENST00000594211.1
ENST00000376832.4 |
KLK9
|
kallikrein-related peptidase 9 |
| chr10_-_125853200 | 6.61 |
ENST00000421115.1
|
CHST15
|
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
| chr12_-_28123206 | 6.55 |
ENST00000542963.1
ENST00000535992.1 |
PTHLH
|
parathyroid hormone-like hormone |
| chr3_-_12800751 | 5.94 |
ENST00000435218.2
ENST00000435575.1 |
TMEM40
|
transmembrane protein 40 |
| chr19_+_45409011 | 5.88 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
| chr9_-_139891165 | 5.87 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
| chr3_+_9944492 | 5.72 |
ENST00000383814.3
ENST00000454190.2 ENST00000454992.1 |
IL17RE
|
interleukin 17 receptor E |
| chr11_+_93754513 | 5.71 |
ENST00000315765.9
|
HEPHL1
|
hephaestin-like 1 |
| chr8_-_125740514 | 5.69 |
ENST00000325064.5
ENST00000518547.1 |
MTSS1
|
metastasis suppressor 1 |
| chr11_-_14379997 | 5.58 |
ENST00000526063.1
ENST00000532814.1 |
RRAS2
|
related RAS viral (r-ras) oncogene homolog 2 |
| chr10_+_24497704 | 5.58 |
ENST00000376456.4
ENST00000458595.1 |
KIAA1217
|
KIAA1217 |
| chr4_+_184020398 | 5.54 |
ENST00000403733.3
ENST00000378925.3 |
WWC2
|
WW and C2 domain containing 2 |
| chr3_-_69590486 | 5.37 |
ENST00000497880.1
|
FRMD4B
|
FERM domain containing 4B |
| chr17_+_37030127 | 5.29 |
ENST00000419929.1
|
LASP1
|
LIM and SH3 protein 1 |
| chr1_+_230193521 | 5.22 |
ENST00000543760.1
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
| chr6_+_30850862 | 5.22 |
ENST00000504651.1
ENST00000512694.1 ENST00000515233.1 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr1_-_201346761 | 5.19 |
ENST00000455702.1
ENST00000422165.1 ENST00000367318.5 ENST00000367320.2 ENST00000438742.1 ENST00000412633.1 ENST00000458432.2 ENST00000421663.2 ENST00000367322.1 ENST00000509001.1 |
TNNT2
|
troponin T type 2 (cardiac) |
| chr5_-_150138246 | 5.13 |
ENST00000518015.1
|
DCTN4
|
dynactin 4 (p62) |
| chr9_+_112542591 | 5.13 |
ENST00000483909.1
ENST00000314527.4 ENST00000413420.1 ENST00000302798.7 ENST00000555236.1 ENST00000510514.5 |
PALM2
PALM2-AKAP2
AKAP2
|
paralemmin 2 PALM2-AKAP2 readthrough A kinase (PRKA) anchor protein 2 |
| chr1_+_78354297 | 5.11 |
ENST00000334785.7
|
NEXN
|
nexilin (F actin binding protein) |
| chr7_+_134464376 | 5.00 |
ENST00000454108.1
ENST00000361675.2 |
CALD1
|
caldesmon 1 |
| chr1_+_78354330 | 4.97 |
ENST00000440324.1
|
NEXN
|
nexilin (F actin binding protein) |
| chr7_+_134430212 | 4.92 |
ENST00000436461.2
|
CALD1
|
caldesmon 1 |
| chr2_-_161264385 | 4.77 |
ENST00000409972.1
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
| chr1_+_152974218 | 4.72 |
ENST00000331860.3
ENST00000443178.1 ENST00000295367.4 |
SPRR3
|
small proline-rich protein 3 |
| chr1_+_26503894 | 4.68 |
ENST00000361530.6
ENST00000374253.5 |
CNKSR1
|
connector enhancer of kinase suppressor of Ras 1 |
| chr11_-_8832182 | 4.63 |
ENST00000527510.1
ENST00000528527.1 ENST00000528523.1 ENST00000313726.6 |
ST5
|
suppression of tumorigenicity 5 |
| chr8_+_144816303 | 4.62 |
ENST00000533004.1
|
FAM83H-AS1
|
FAM83H antisense RNA 1 (head to head) |
| chr4_-_152149033 | 4.55 |
ENST00000514152.1
|
SH3D19
|
SH3 domain containing 19 |
| chr17_+_73717551 | 4.53 |
ENST00000450894.3
|
ITGB4
|
integrin, beta 4 |
| chr7_+_116165038 | 4.50 |
ENST00000393470.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr11_+_66824346 | 4.48 |
ENST00000532559.1
|
RHOD
|
ras homolog family member D |
| chr6_+_41604747 | 4.46 |
ENST00000419164.1
ENST00000373051.2 |
MDFI
|
MyoD family inhibitor |
| chr3_-_185538849 | 4.43 |
ENST00000421047.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
| chr17_-_65242063 | 4.40 |
ENST00000581159.1
|
HELZ
|
helicase with zinc finger |
| chr1_-_209825674 | 4.34 |
ENST00000367030.3
ENST00000356082.4 |
LAMB3
|
laminin, beta 3 |
| chr19_-_51504852 | 4.31 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
| chr17_+_73717407 | 4.29 |
ENST00000579662.1
|
ITGB4
|
integrin, beta 4 |
| chr15_+_41136216 | 4.26 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr6_-_143266297 | 4.21 |
ENST00000367603.2
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2 |
| chr16_-_2908155 | 4.20 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
| chr3_+_9944303 | 4.19 |
ENST00000421412.1
ENST00000295980.3 |
IL17RE
|
interleukin 17 receptor E |
| chr4_-_185729602 | 4.16 |
ENST00000437665.3
|
ACSL1
|
acyl-CoA synthetase long-chain family member 1 |
| chr15_+_96869165 | 4.16 |
ENST00000421109.2
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr19_-_49567124 | 4.14 |
ENST00000301411.3
|
NTF4
|
neurotrophin 4 |
| chr11_-_62313090 | 4.10 |
ENST00000528508.1
ENST00000533365.1 |
AHNAK
|
AHNAK nucleoprotein |
| chr16_+_53920795 | 4.09 |
ENST00000431610.2
ENST00000460382.1 |
FTO
|
fat mass and obesity associated |
| chr14_+_65170820 | 4.08 |
ENST00000555982.1
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
| chr17_+_73717516 | 4.02 |
ENST00000200181.3
ENST00000339591.3 |
ITGB4
|
integrin, beta 4 |
| chr6_-_35464817 | 3.99 |
ENST00000338863.7
|
TEAD3
|
TEA domain family member 3 |
| chr5_-_39424961 | 3.98 |
ENST00000503513.1
|
DAB2
|
Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
| chr19_-_14606900 | 3.96 |
ENST00000393029.3
ENST00000393028.1 ENST00000393033.4 ENST00000345425.2 ENST00000586027.1 ENST00000591349.1 ENST00000587210.1 |
GIPC1
|
GIPC PDZ domain containing family, member 1 |
| chr22_-_36761081 | 3.92 |
ENST00000456729.1
ENST00000401701.1 |
MYH9
|
myosin, heavy chain 9, non-muscle |
| chr6_-_35464727 | 3.88 |
ENST00000402886.3
|
TEAD3
|
TEA domain family member 3 |
| chr1_+_78354243 | 3.88 |
ENST00000294624.8
|
NEXN
|
nexilin (F actin binding protein) |
| chr18_+_32173276 | 3.87 |
ENST00000591816.1
ENST00000588125.1 ENST00000598334.1 ENST00000588684.1 ENST00000554864.3 ENST00000399121.5 ENST00000595022.1 ENST00000269190.7 ENST00000399097.3 |
DTNA
|
dystrobrevin, alpha |
| chr3_+_190105909 | 3.86 |
ENST00000456423.1
|
CLDN16
|
claudin 16 |
| chr11_-_125365435 | 3.84 |
ENST00000524435.1
|
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
| chrX_-_48325857 | 3.84 |
ENST00000376875.1
|
SLC38A5
|
solute carrier family 38, member 5 |
| chr4_-_119274121 | 3.81 |
ENST00000296498.3
|
PRSS12
|
protease, serine, 12 (neurotrypsin, motopsin) |
| chr20_-_44540686 | 3.76 |
ENST00000477313.1
ENST00000542937.1 ENST00000372431.3 ENST00000354050.4 ENST00000420868.2 |
PLTP
|
phospholipid transfer protein |
| chr11_+_94439591 | 3.66 |
ENST00000299004.9
|
AMOTL1
|
angiomotin like 1 |
| chr10_+_5488564 | 3.66 |
ENST00000449083.1
ENST00000380359.3 |
NET1
|
neuroepithelial cell transforming 1 |
| chr2_-_216257849 | 3.63 |
ENST00000456923.1
|
FN1
|
fibronectin 1 |
| chr7_-_143105941 | 3.62 |
ENST00000275815.3
|
EPHA1
|
EPH receptor A1 |
| chr15_-_42565606 | 3.60 |
ENST00000307216.6
ENST00000448392.1 |
TMEM87A
|
transmembrane protein 87A |
| chr12_-_96184913 | 3.59 |
ENST00000538383.1
|
NTN4
|
netrin 4 |
| chr12_+_27677085 | 3.57 |
ENST00000545334.1
ENST00000540114.1 ENST00000537927.1 ENST00000318304.8 ENST00000535047.1 ENST00000542629.1 ENST00000228425.6 |
PPFIBP1
|
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
| chr19_-_54984354 | 3.57 |
ENST00000301200.2
|
CDC42EP5
|
CDC42 effector protein (Rho GTPase binding) 5 |
| chr16_+_30907927 | 3.56 |
ENST00000279804.2
ENST00000395019.3 |
CTF1
|
cardiotrophin 1 |
| chr20_+_35169885 | 3.54 |
ENST00000279022.2
ENST00000346786.2 |
MYL9
|
myosin, light chain 9, regulatory |
| chr19_-_14048804 | 3.52 |
ENST00000254320.3
ENST00000586075.1 |
PODNL1
|
podocan-like 1 |
| chr9_+_112542572 | 3.44 |
ENST00000374530.3
|
PALM2-AKAP2
|
PALM2-AKAP2 readthrough |
| chr12_-_54813229 | 3.44 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
| chr4_+_169552748 | 3.43 |
ENST00000504519.1
ENST00000512127.1 |
PALLD
|
palladin, cytoskeletal associated protein |
| chr2_+_210444748 | 3.42 |
ENST00000392194.1
|
MAP2
|
microtubule-associated protein 2 |
| chr6_+_41604620 | 3.41 |
ENST00000432027.1
|
MDFI
|
MyoD family inhibitor |
| chr6_-_47009996 | 3.40 |
ENST00000371243.2
|
GPR110
|
G protein-coupled receptor 110 |
| chr10_+_99344104 | 3.37 |
ENST00000555577.1
ENST00000370649.3 |
PI4K2A
PI4K2A
|
phosphatidylinositol 4-kinase type 2 alpha Phosphatidylinositol 4-kinase type 2-alpha; Uncharacterized protein |
| chrX_+_99899180 | 3.36 |
ENST00000373004.3
|
SRPX2
|
sushi-repeat containing protein, X-linked 2 |
| chr1_+_19967014 | 3.35 |
ENST00000428975.1
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist |
| chr1_-_94050668 | 3.35 |
ENST00000539242.1
|
BCAR3
|
breast cancer anti-estrogen resistance 3 |
| chr5_+_118668846 | 3.30 |
ENST00000513374.1
|
TNFAIP8
|
tumor necrosis factor, alpha-induced protein 8 |
| chr17_+_7255208 | 3.28 |
ENST00000333751.3
|
KCTD11
|
potassium channel tetramerization domain containing 11 |
| chr8_-_94753202 | 3.27 |
ENST00000521947.1
|
RBM12B
|
RNA binding motif protein 12B |
| chr11_+_129245796 | 3.27 |
ENST00000281437.4
|
BARX2
|
BARX homeobox 2 |
| chr5_+_49962772 | 3.26 |
ENST00000281631.5
ENST00000513738.1 ENST00000503665.1 ENST00000514067.2 ENST00000503046.1 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
| chr11_-_8892900 | 3.25 |
ENST00000526155.1
ENST00000524757.1 ENST00000527392.1 ENST00000534665.1 ENST00000525169.1 ENST00000527516.1 ENST00000533471.1 |
ST5
|
suppression of tumorigenicity 5 |
| chr5_+_154136702 | 3.24 |
ENST00000524248.1
|
LARP1
|
La ribonucleoprotein domain family, member 1 |
| chr1_+_12538594 | 3.22 |
ENST00000543710.1
|
VPS13D
|
vacuolar protein sorting 13 homolog D (S. cerevisiae) |
| chr8_-_94753184 | 3.20 |
ENST00000520560.1
|
RBM12B
|
RNA binding motif protein 12B |
| chr2_-_153573887 | 3.18 |
ENST00000493468.2
ENST00000545856.1 |
PRPF40A
|
PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) |
| chr11_-_118661588 | 3.16 |
ENST00000534980.1
ENST00000526070.2 |
DDX6
|
DEAD (Asp-Glu-Ala-Asp) box helicase 6 |
| chr5_+_145316120 | 3.16 |
ENST00000359120.4
|
SH3RF2
|
SH3 domain containing ring finger 2 |
| chr17_+_66511540 | 3.15 |
ENST00000588188.2
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
| chr5_-_150138061 | 3.15 |
ENST00000521533.1
ENST00000424236.1 |
DCTN4
|
dynactin 4 (p62) |
| chr3_+_185304059 | 3.14 |
ENST00000427465.2
|
SENP2
|
SUMO1/sentrin/SMT3 specific peptidase 2 |
| chr6_+_106959718 | 3.09 |
ENST00000369066.3
|
AIM1
|
absent in melanoma 1 |
| chr6_-_47010061 | 3.05 |
ENST00000371253.2
|
GPR110
|
G protein-coupled receptor 110 |
| chr8_-_94752946 | 3.04 |
ENST00000519109.1
|
RBM12B
|
RNA binding motif protein 12B |
| chr15_+_41136734 | 3.01 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr15_+_41136586 | 3.00 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr12_-_498415 | 2.99 |
ENST00000535014.1
ENST00000543507.1 ENST00000544760.1 |
KDM5A
|
lysine (K)-specific demethylase 5A |
| chr17_+_66511224 | 2.98 |
ENST00000588178.1
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha |
| chr1_+_178310581 | 2.96 |
ENST00000462775.1
|
RASAL2
|
RAS protein activator like 2 |
| chr12_-_8815404 | 2.94 |
ENST00000359478.2
ENST00000396549.2 |
MFAP5
|
microfibrillar associated protein 5 |
| chr1_+_86046433 | 2.89 |
ENST00000451137.2
|
CYR61
|
cysteine-rich, angiogenic inducer, 61 |
| chr5_-_149682447 | 2.89 |
ENST00000328668.7
|
ARSI
|
arylsulfatase family, member I |
| chr6_+_163837347 | 2.84 |
ENST00000544436.1
|
QKI
|
QKI, KH domain containing, RNA binding |
| chr9_+_72658490 | 2.84 |
ENST00000377182.4
|
MAMDC2
|
MAM domain containing 2 |
| chr5_-_148442584 | 2.77 |
ENST00000394358.2
ENST00000512049.1 |
SH3TC2
|
SH3 domain and tetratricopeptide repeats 2 |
| chr6_+_44094627 | 2.73 |
ENST00000259746.9
|
TMEM63B
|
transmembrane protein 63B |
| chr11_-_8832521 | 2.70 |
ENST00000530438.1
|
ST5
|
suppression of tumorigenicity 5 |
| chr3_+_169940153 | 2.68 |
ENST00000295797.4
|
PRKCI
|
protein kinase C, iota |
| chr11_+_45944190 | 2.67 |
ENST00000401752.1
ENST00000389968.3 ENST00000325468.5 ENST00000536139.1 |
GYLTL1B
|
glycosyltransferase-like 1B |
| chr1_+_62417957 | 2.64 |
ENST00000307297.7
ENST00000543708.1 |
INADL
|
InaD-like (Drosophila) |
| chr4_-_40631859 | 2.64 |
ENST00000295971.7
ENST00000319592.4 |
RBM47
|
RNA binding motif protein 47 |
| chr8_+_94929969 | 2.63 |
ENST00000517764.1
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
| chr11_-_57194218 | 2.62 |
ENST00000529554.1
|
SLC43A3
|
solute carrier family 43, member 3 |
| chr15_+_42565393 | 2.60 |
ENST00000561871.1
|
GANC
|
glucosidase, alpha; neutral C |
| chr1_-_95391315 | 2.60 |
ENST00000545882.1
ENST00000415017.1 |
CNN3
|
calponin 3, acidic |
| chr15_+_42565844 | 2.57 |
ENST00000566442.1
|
GANC
|
glucosidase, alpha; neutral C |
| chr12_-_118490403 | 2.53 |
ENST00000535496.1
|
WSB2
|
WD repeat and SOCS box containing 2 |
| chr6_-_75915757 | 2.53 |
ENST00000322507.8
|
COL12A1
|
collagen, type XII, alpha 1 |
| chr13_-_86373536 | 2.53 |
ENST00000400286.2
|
SLITRK6
|
SLIT and NTRK-like family, member 6 |
| chr5_-_150138551 | 2.52 |
ENST00000446090.2
ENST00000447998.2 |
DCTN4
|
dynactin 4 (p62) |
| chr3_+_118892411 | 2.51 |
ENST00000479520.1
ENST00000494855.1 |
UPK1B
|
uroplakin 1B |
| chr19_-_51456198 | 2.50 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
| chr12_-_122241812 | 2.46 |
ENST00000538335.1
|
AC084018.1
|
AC084018.1 |
| chr6_+_143999185 | 2.43 |
ENST00000542769.1
ENST00000397980.3 |
PHACTR2
|
phosphatase and actin regulator 2 |
| chr11_-_118122996 | 2.42 |
ENST00000525386.1
ENST00000527472.1 ENST00000278949.4 |
MPZL3
|
myelin protein zero-like 3 |
| chr1_+_36771946 | 2.42 |
ENST00000373139.2
ENST00000453908.2 ENST00000426732.2 |
SH3D21
|
SH3 domain containing 21 |
| chr14_-_23623577 | 2.42 |
ENST00000422941.2
ENST00000453702.1 |
SLC7A8
|
solute carrier family 7 (amino acid transporter light chain, L system), member 8 |
| chr4_+_76649753 | 2.42 |
ENST00000603759.1
|
USO1
|
USO1 vesicle transport factor |
| chr10_+_23728198 | 2.39 |
ENST00000376495.3
|
OTUD1
|
OTU domain containing 1 |
| chr3_-_47932759 | 2.39 |
ENST00000441748.2
ENST00000335271.5 |
MAP4
|
microtubule-associated protein 4 |
| chr16_-_4164027 | 2.39 |
ENST00000572288.1
|
ADCY9
|
adenylate cyclase 9 |
| chr17_+_7348658 | 2.35 |
ENST00000570557.1
ENST00000536404.2 ENST00000576360.1 |
CHRNB1
|
cholinergic receptor, nicotinic, beta 1 (muscle) |
| chr11_-_8892464 | 2.31 |
ENST00000527347.1
ENST00000526241.1 ENST00000526126.1 ENST00000530938.1 ENST00000526057.1 |
ST5
|
suppression of tumorigenicity 5 |
| chr7_+_116165754 | 2.31 |
ENST00000405348.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
| chr9_-_35754253 | 2.26 |
ENST00000436428.2
|
MSMP
|
microseminoprotein, prostate associated |
| chr7_+_134464414 | 2.25 |
ENST00000361901.2
|
CALD1
|
caldesmon 1 |
| chr12_-_8815215 | 2.23 |
ENST00000544889.1
ENST00000543369.1 |
MFAP5
|
microfibrillar associated protein 5 |
| chr12_-_8815477 | 2.23 |
ENST00000433590.2
|
MFAP5
|
microfibrillar associated protein 5 |
| chr15_-_42565023 | 2.20 |
ENST00000566474.1
|
TMEM87A
|
transmembrane protein 87A |
| chr4_-_74088800 | 2.19 |
ENST00000509867.2
|
ANKRD17
|
ankyrin repeat domain 17 |
| chr1_-_109935819 | 2.18 |
ENST00000538502.1
|
SORT1
|
sortilin 1 |
| chr14_+_65171099 | 2.18 |
ENST00000247226.7
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3 |
| chr15_+_41136369 | 2.17 |
ENST00000563656.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr4_-_186733363 | 2.16 |
ENST00000393523.2
ENST00000393528.3 ENST00000449407.2 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr10_-_101673782 | 2.15 |
ENST00000422692.1
|
DNMBP
|
dynamin binding protein |
| chr14_-_24733444 | 2.15 |
ENST00000560478.1
ENST00000560443.1 |
TGM1
|
transglutaminase 1 |
| chr5_-_148442687 | 2.15 |
ENST00000515425.1
|
SH3TC2
|
SH3 domain and tetratricopeptide repeats 2 |
| chr9_+_34989638 | 2.12 |
ENST00000453597.3
ENST00000335998.3 ENST00000312316.5 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
| chrX_-_135056106 | 2.12 |
ENST00000433339.2
|
MMGT1
|
membrane magnesium transporter 1 |
| chr1_+_100316041 | 2.12 |
ENST00000370165.3
ENST00000370163.3 ENST00000294724.4 |
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
| chr11_-_111782696 | 2.11 |
ENST00000227251.3
ENST00000526180.1 |
CRYAB
|
crystallin, alpha B |
| chr8_-_141728760 | 2.11 |
ENST00000430260.2
|
PTK2
|
protein tyrosine kinase 2 |
| chr5_-_127674883 | 2.11 |
ENST00000507835.1
|
FBN2
|
fibrillin 2 |
| chr11_-_57194111 | 2.10 |
ENST00000529112.1
ENST00000529896.1 |
SLC43A3
|
solute carrier family 43, member 3 |
| chr6_+_35996859 | 2.08 |
ENST00000472333.1
|
MAPK14
|
mitogen-activated protein kinase 14 |
| chr12_-_8815299 | 2.07 |
ENST00000535336.1
|
MFAP5
|
microfibrillar associated protein 5 |
| chr1_+_100315613 | 2.07 |
ENST00000361915.3
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase |
| chr12_-_120687948 | 2.06 |
ENST00000458477.2
|
PXN
|
paxillin |
| chr7_-_137686791 | 2.06 |
ENST00000452463.1
ENST00000330387.6 ENST00000456390.1 |
CREB3L2
|
cAMP responsive element binding protein 3-like 2 |
| chr7_+_18548878 | 2.06 |
ENST00000456174.2
|
HDAC9
|
histone deacetylase 9 |
| chr4_-_83719983 | 2.05 |
ENST00000319540.4
|
SCD5
|
stearoyl-CoA desaturase 5 |
| chr12_-_47219733 | 2.04 |
ENST00000547477.1
ENST00000447411.1 ENST00000266579.4 |
SLC38A4
|
solute carrier family 38, member 4 |
| chr3_+_57741957 | 2.04 |
ENST00000295951.3
|
SLMAP
|
sarcolemma associated protein |
| chr15_+_42565464 | 2.03 |
ENST00000562170.1
ENST00000562859.1 |
GANC
|
glucosidase, alpha; neutral C |
| chr2_-_111230393 | 2.03 |
ENST00000447537.2
ENST00000413601.2 |
LIMS3L
LIMS3L
|
LIM and senescent cell antigen-like-containing domain protein 3; Uncharacterized protein; cDNA FLJ59124, highly similar to Particularly interesting newCys-His protein; cDNA, FLJ79109, highly similar to Particularly interesting newCys-His protein LIM and senescent cell antigen-like domains 3-like |
| chrX_+_134654540 | 2.02 |
ENST00000370752.4
|
DDX26B
|
DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 26B |
| chr5_+_36608422 | 2.02 |
ENST00000381918.3
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr11_-_85780853 | 2.02 |
ENST00000531930.1
ENST00000528398.1 |
PICALM
|
phosphatidylinositol binding clathrin assembly protein |
| chr15_-_42565221 | 2.01 |
ENST00000563371.1
ENST00000568400.1 ENST00000568432.1 |
TMEM87A
|
transmembrane protein 87A |
| chr17_-_40575535 | 2.00 |
ENST00000357037.5
|
PTRF
|
polymerase I and transcript release factor |
| chr5_+_148443049 | 1.94 |
ENST00000515304.1
ENST00000507318.1 |
CTC-529P8.1
|
CTC-529P8.1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of TEAD3_TEAD1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.6 | 13.8 | GO:0002605 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of dendritic cell antigen processing and presentation(GO:0002605) negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 2.3 | 6.8 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 2.0 | 5.9 | GO:2000646 | lipid transport involved in lipid storage(GO:0010877) positive regulation of receptor catabolic process(GO:2000646) |
| 1.4 | 28.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 1.4 | 4.1 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 1.4 | 4.1 | GO:0042245 | RNA repair(GO:0042245) |
| 1.2 | 12.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 1.2 | 3.7 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 1.2 | 3.6 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
| 1.1 | 4.5 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.1 | 3.4 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 1.1 | 9.9 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 1.1 | 3.3 | GO:0006738 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 1.1 | 4.2 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 1.0 | 4.2 | GO:0009956 | radial pattern formation(GO:0009956) |
| 1.0 | 4.1 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 1.0 | 8.9 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 1.0 | 17.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.9 | 34.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.9 | 17.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.9 | 5.2 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.8 | 5.7 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.8 | 3.9 | GO:0032796 | uropod organization(GO:0032796) |
| 0.8 | 3.8 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.7 | 7.9 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.7 | 2.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.7 | 4.7 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.7 | 3.4 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.7 | 9.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.6 | 4.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.6 | 3.8 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.6 | 3.7 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.6 | 12.1 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.6 | 4.7 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.6 | 2.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.6 | 1.7 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.6 | 1.7 | GO:0034059 | response to anoxia(GO:0034059) |
| 0.5 | 3.2 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.5 | 13.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.5 | 9.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.5 | 1.5 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.5 | 1.0 | GO:0060532 | bronchus cartilage development(GO:0060532) lung smooth muscle development(GO:0061145) |
| 0.5 | 13.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.5 | 10.8 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.5 | 1.4 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.5 | 3.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.4 | 2.6 | GO:0072658 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.4 | 4.4 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.4 | 2.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.4 | 2.5 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.4 | 2.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.4 | 2.9 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.4 | 7.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.4 | 1.5 | GO:0008354 | germ cell migration(GO:0008354) |
| 0.4 | 2.6 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.4 | 2.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.3 | 8.4 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.3 | 1.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.3 | 1.7 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.3 | 4.7 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.3 | 1.0 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.3 | 1.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.3 | 4.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.3 | 4.2 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.3 | 3.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.3 | 6.1 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.3 | 3.8 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.3 | 0.9 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.3 | 2.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.3 | 1.1 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.3 | 1.6 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 | 3.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.3 | 4.9 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.3 | 4.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.3 | 5.0 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.3 | 1.8 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.3 | 1.3 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.3 | 18.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
| 0.3 | 1.0 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 | 1.5 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.2 | 3.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 | 2.7 | GO:0070777 | gamma-aminobutyric acid biosynthetic process(GO:0009449) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.2 | 1.4 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 | 1.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.2 | 3.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.2 | 1.6 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.2 | 2.1 | GO:0030242 | pexophagy(GO:0030242) |
| 0.2 | 5.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.2 | 0.7 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 0.2 | 1.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.2 | 3.1 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.2 | 1.5 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.2 | 1.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.2 | 3.2 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.2 | 3.8 | GO:0015816 | glycine transport(GO:0015816) |
| 0.2 | 2.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.2 | 1.0 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.2 | 1.0 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 | 1.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.2 | 1.4 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.2 | 32.2 | GO:0070268 | cornification(GO:0070268) |
| 0.2 | 1.2 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.2 | 1.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.2 | 2.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.2 | 1.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 | 1.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.2 | 9.5 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.2 | 1.5 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.2 | 1.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.2 | 0.5 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.2 | 0.9 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.2 | 0.7 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.2 | 0.8 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.2 | 2.0 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.2 | 1.2 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
| 0.2 | 0.8 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.2 | 1.9 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.2 | 3.4 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.2 | 4.2 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.2 | 5.3 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.2 | 2.9 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.2 | 2.1 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.1 | 3.3 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 | 2.6 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.1 | 1.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 1.6 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.1 | 2.1 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.1 | 0.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 | 1.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.1 | 6.3 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 | 6.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 1.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.1 | 0.5 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
| 0.1 | 5.4 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
| 0.1 | 4.0 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 | 1.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.1 | 2.9 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 0.9 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.1 | 0.6 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.1 | 2.7 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
| 0.1 | 0.3 | GO:0030070 | insulin processing(GO:0030070) |
| 0.1 | 3.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.1 | 1.3 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 2.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 2.7 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 | 1.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 | 0.4 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.1 | 1.7 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 1.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 0.6 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 | 0.2 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 0.1 | 0.6 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 | 0.3 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.1 | 0.4 | GO:1903613 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.1 | 0.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 | 0.4 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 12.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.1 | 0.5 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.1 | 2.4 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.1 | 3.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.1 | 2.5 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.1 | 0.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.1 | 0.7 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
| 0.1 | 0.4 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
| 0.1 | 0.8 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 | 0.8 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.1 | 0.4 | GO:0021778 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 | 1.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 | 0.8 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.1 | 1.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 3.6 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 | 6.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 2.0 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
| 0.1 | 0.5 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
| 0.1 | 0.6 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 | 1.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 | 0.6 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.1 | 0.2 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 0.0 | 0.3 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 | 0.1 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.0 | 1.8 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.0 | 0.9 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.0 | 1.0 | GO:0035966 | response to unfolded protein(GO:0006986) response to topologically incorrect protein(GO:0035966) |
| 0.0 | 0.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.0 | 1.4 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
| 0.0 | 0.1 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
| 0.0 | 0.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.0 | 1.0 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 | 0.2 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 0.0 | 2.4 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
| 0.0 | 0.3 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.0 | 1.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.0 | 0.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.0 | 2.6 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.0 | 1.8 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.0 | 1.0 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.0 | 1.8 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.0 | 0.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 | 10.0 | GO:0008360 | regulation of cell shape(GO:0008360) |
| 0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.0 | 1.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 | 1.4 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.0 | 5.0 | GO:0007163 | establishment or maintenance of cell polarity(GO:0007163) |
| 0.0 | 8.6 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.0 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
| 0.0 | 2.0 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
| 0.0 | 1.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 0.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.0 | 2.9 | GO:0021954 | central nervous system neuron development(GO:0021954) |
| 0.0 | 1.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 | 1.2 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 | 0.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.0 | 1.6 | GO:0046785 | microtubule polymerization(GO:0046785) |
| 0.0 | 0.2 | GO:0002729 | positive regulation of natural killer cell cytokine production(GO:0002729) |
| 0.0 | 1.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.0 | 3.8 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.0 | 0.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 | 1.2 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.0 | 4.3 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 | 4.0 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.0 | 0.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.0 | 1.4 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.0 | 0.6 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.0 | 0.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.0 | 0.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.3 | 17.4 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 2.0 | 5.9 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.9 | 13.8 | GO:0030478 | actin cap(GO:0030478) |
| 0.9 | 3.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.8 | 2.5 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 0.7 | 4.3 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.7 | 4.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.7 | 3.4 | GO:0035838 | growing cell tip(GO:0035838) |
| 0.6 | 9.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.6 | 10.8 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.5 | 2.1 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.5 | 1.5 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
| 0.5 | 8.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.4 | 3.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.4 | 10.8 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.4 | 12.8 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.4 | 4.3 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.4 | 5.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.4 | 2.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.3 | 3.8 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.3 | 2.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.3 | 1.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.3 | 4.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.3 | 4.5 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.3 | 14.6 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.3 | 8.2 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.3 | 3.8 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.2 | 6.1 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.2 | 1.2 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.2 | 3.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.2 | 3.2 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.2 | 1.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.2 | 1.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.2 | 0.5 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.2 | 1.2 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.2 | 1.3 | GO:0070695 | FHF complex(GO:0070695) |
| 0.2 | 1.4 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.2 | 0.5 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.1 | 24.2 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 5.2 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 0.3 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.1 | 1.5 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.1 | 13.8 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 3.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 3.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 6.2 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 9.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 0.8 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.1 | 5.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 2.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 3.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 1.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.1 | 2.3 | GO:0036477 | somatodendritic compartment(GO:0036477) |
| 0.1 | 1.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.1 | 1.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 1.2 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.1 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.1 | 6.0 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.1 | 31.2 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 1.2 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 2.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.1 | 7.0 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 1.9 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.1 | 0.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 3.6 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 3.9 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.1 | 5.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.1 | 11.2 | GO:0030018 | Z disc(GO:0030018) |
| 0.1 | 1.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.0 | 3.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 3.5 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.0 | 5.9 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.0 | 4.9 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.0 | 4.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.0 | 5.2 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.0 | 16.7 | GO:0005769 | early endosome(GO:0005769) |
| 0.0 | 1.1 | GO:0030055 | cell-substrate junction(GO:0030055) |
| 0.0 | 4.7 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.0 | 0.2 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.0 | 6.3 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 0.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.0 | 0.5 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.0 | 1.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.9 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.0 | 4.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.6 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 0.8 | GO:0097546 | ciliary base(GO:0097546) |
| 0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.0 | 0.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.0 | 2.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 0.6 | GO:0030424 | axon(GO:0030424) |
| 0.0 | 1.9 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.0 | 0.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.0 | 1.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.0 | 3.9 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 35.0 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 2.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.7 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
| 0.0 | 2.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
| 0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.8 | GO:0000786 | nucleosome(GO:0000786) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.4 | 13.8 | GO:0070052 | collagen V binding(GO:0070052) |
| 2.3 | 6.8 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.5 | 5.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 1.3 | 6.6 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 1.2 | 3.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 1.2 | 17.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 1.1 | 3.3 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 1.1 | 2.2 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 1.1 | 13.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 1.0 | 10.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 1.0 | 14.4 | GO:0038132 | neuregulin binding(GO:0038132) |
| 1.0 | 4.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 1.0 | 4.1 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.8 | 3.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.6 | 5.2 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.6 | 4.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.5 | 4.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.5 | 5.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.4 | 5.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.4 | 1.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.4 | 10.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.4 | 2.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.4 | 1.1 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
| 0.4 | 10.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.4 | 13.9 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.3 | 8.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.3 | 1.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.3 | 1.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.3 | 3.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.3 | 1.9 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.3 | 2.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.3 | 2.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.3 | 1.3 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.3 | 7.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.3 | 10.5 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.3 | 3.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.3 | 3.8 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.3 | 6.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.3 | 3.1 | GO:0036122 | BMP binding(GO:0036122) |
| 0.2 | 1.0 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.2 | 1.7 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.2 | 5.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 2.5 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.2 | 2.1 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.2 | 1.3 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.2 | 2.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.2 | 0.8 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.2 | 1.8 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.2 | 7.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 1.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.2 | 4.0 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.2 | 1.0 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.2 | 2.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.2 | 1.2 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.2 | 1.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.2 | 3.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 5.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.2 | 1.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.2 | 0.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.2 | 21.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.2 | 1.2 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.2 | 14.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 2.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.2 | 7.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 3.6 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.2 | 2.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.2 | 3.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.2 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.1 | 1.0 | GO:0070728 | leucine binding(GO:0070728) |
| 0.1 | 3.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 3.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.1 | 5.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 10.4 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 4.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 4.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.9 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) steroid sulfotransferase activity(GO:0050294) |
| 0.1 | 2.1 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 3.4 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
| 0.1 | 3.8 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.1 | 2.0 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 4.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.1 | 5.2 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 0.6 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.1 | 2.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.1 | 0.5 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.1 | 1.5 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 13.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.4 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 0.1 | 1.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 4.5 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 2.7 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 1.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.1 | 2.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.1 | 3.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 1.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 22.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.1 | 1.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 13.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.1 | 2.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.1 | 3.8 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.1 | 2.8 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 1.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.1 | 2.0 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.1 | 3.6 | GO:0016504 | peptidase activator activity(GO:0016504) |
| 0.1 | 3.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 0.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.1 | 9.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 8.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 1.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.1 | 1.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 0.1 | 9.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 1.4 | GO:0016887 | ATPase activity(GO:0016887) |
| 0.1 | 0.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 0.0 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.0 | 2.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 1.1 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 0.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.0 | 5.5 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.0 | 8.3 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.0 | 2.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.0 | 1.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 4.5 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
| 0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.0 | 0.1 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.0 | 0.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.0 | 0.7 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.0 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.0 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.0 | 1.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.0 | 1.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
| 0.0 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 0.0 | 0.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.0 | 1.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 4.2 | GO:0004386 | helicase activity(GO:0004386) |
| 0.0 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) amylase activity(GO:0016160) |
| 0.0 | 2.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.0 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.0 | 0.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.0 | 0.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.0 | 0.2 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.0 | 0.4 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.0 | 3.6 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 0.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.0 | 1.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 2.5 | GO:0051213 | dioxygenase activity(GO:0051213) |
| 0.0 | 1.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.0 | 6.9 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 0.4 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.0 | 2.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 1.3 | GO:0019003 | GDP binding(GO:0019003) |
| 0.0 | 0.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.0 | 4.4 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.0 | 0.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 34.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.4 | 25.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.4 | 28.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.2 | 8.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 4.7 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 9.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 6.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
| 0.1 | 8.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.1 | 2.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 1.3 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.1 | 4.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.1 | 4.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 8.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 9.5 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 10.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.1 | 2.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.1 | 1.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 5.0 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 5.7 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 6.6 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.1 | 2.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 3.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 2.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.1 | 4.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 4.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.0 | 2.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 2.3 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 4.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 0.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 2.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 6.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 2.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.0 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.0 | 0.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.0 | 1.6 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.7 | PID E2F PATHWAY | E2F transcription factor network |
| 0.0 | 0.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 9.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.2 | 5.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.2 | 11.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.2 | 6.8 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.2 | 4.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.2 | 6.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.2 | 8.5 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.2 | 3.8 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.2 | 6.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 2.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.1 | 4.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 2.6 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 4.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 5.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 3.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.1 | 19.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 5.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 9.6 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 1.2 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.1 | 1.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 2.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 1.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.1 | 2.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.1 | 5.6 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 2.7 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.1 | 11.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 18.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 1.6 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.1 | 2.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 3.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.1 | 2.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 2.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.1 | 2.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.1 | 5.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 1.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.0 | 1.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.0 | 2.3 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.0 | 1.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 4.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 1.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.0 | 2.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.0 | 3.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.0 | 0.9 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 1.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 1.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 1.8 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 1.1 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 2.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 1.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |